Related Experiment Videos
Autoimmunity in the eye and its regulation
1National Eye Institute, NIH, Bethesda.
Current Opinion in Immunology
|December 1, 1994
Summary
Researchers explored autoimmune intraocular inflammation (uveitis) and its suppression. New findings reveal uveitis triggers, pathogenic steps, specific lymphocytes, and immune tolerance mechanisms that can treat ocular inflammation.
Area of Science:
- Ophthalmology
- Immunology
- Autoimmunity
Background:
- Autoimmune intraocular inflammation, or uveitis, is a significant cause of vision loss.
- Understanding the immune mechanisms underlying uveitis is crucial for developing effective treatments.
Purpose of the Study:
- To investigate novel uveitogenic antigens and reactions.
- To dissect the early pathogenic steps of uveitis.
- To elucidate the immune suppression mechanisms, including anterior chamber-associated immune deviation and oral tolerance, that regulate ocular inflammation.
Main Methods:
- Identification of uveitogenic antigens and associated immune responses.
- Analysis of lymphocyte subsets infiltrating the inflamed eye.
- Investigation of immune tolerance mechanisms, specifically anterior chamber-associated immune deviation and oral tolerance.
Main Results:
- Discovery of new uveitogenic antigens and reactions.
- Detailed understanding of early pathogenic processes in uveitis.
- Identification of specific lymphocyte subsets involved in ocular inflammation.
- Elucidation of anterior chamber-associated immune deviation and oral tolerance as key regulators of ocular immunity.
- Demonstration of the therapeutic potential of these immune mechanisms in treating uveitis.
Conclusions:
- Recent advances have significantly expanded our knowledge of uveitis development and immune regulation in the eye.
- Immune tolerance mechanisms, such as anterior chamber-associated immune deviation and oral tolerance, hold promise for inhibiting and treating ocular inflammation.